旁观者
发表于 2025-3-25 06:16:33
The Pharmaceutical Industry in 2010,t premium prices. There was little fear of a real competitive challenge, as competition was based not on price but on the ability to introduce a steady stream of patent-protected new products into a steadily growing market.
TAG
发表于 2025-3-25 08:57:17
http://reply.papertrans.cn/43/4247/424628/424628_22.png
AVERT
发表于 2025-3-25 15:03:55
Conference proceedings 1994by governments, as payers become more conscious and influential in their decisions about shaping therapies, and as consumers become more involved in directing their own health care, health care providers and pharmaceutical companies are being challenged to rethink the way they do business. This volu
为宠爱
发表于 2025-3-25 18:45:52
0947-6075 ntroduced by governments, as payers become more conscious and influential in their decisions about shaping therapies, and as consumers become more involved in directing their own health care, health care providers and pharmaceutical companies are being challenged to rethink the way they do business.
Urgency
发表于 2025-3-25 19:59:15
http://reply.papertrans.cn/43/4247/424628/424628_25.png
山崩
发表于 2025-3-26 01:58:46
Ernst Schering Foundation Symposium Proceedingshttp://image.papertrans.cn/h/image/424628.jpg
Blatant
发表于 2025-3-26 04:35:01
Health Care Information Systems in 2010: Implications for the Pharmaceutical Industry,selves at risk. The push of technological developments and the pull of desired applications will lead the United States, Europe, and Japan to refashion health information systems. Companies in each of these markets that join the race to add value to the growing health information network will reap commensurate rewards.
Saline
发表于 2025-3-26 11:22:33
http://reply.papertrans.cn/43/4247/424628/424628_28.png
refine
发表于 2025-3-26 16:04:30
The Future of Pharmaceutical Therapy and Regulation,Physicians will continue to be dominant in decisions about drug prescribing, but clinical pharmacists employed by hospitals and health maintenance organizations will exert power in formulary decisions and in drug purchasing negotiations. Marketing must take this into account.
BLINK
发表于 2025-3-26 20:43:04
Pharmaceuticals and Health Care in Japan Through 2010,To understand the future of pharmaceuticals and health care in Japan, it is necessary to review current trends, to understand not only differences in systems, customs, and culture, but also the procedures used to reach conclusions and decisions. Thus this report is divided into three parts: